Question: is ampyra a rems drug?
Answer: RISK EVALUATION AND MITIGATION STRATEGY REQUIREMENTS The REMS for Ampyra (dalfampridine) was originally approved on January 22, 2010, and the most recent REMS modification was approved on July 20, 2012.